Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. 9-((2-hydroxyethoxy)methyl)guanine
2. Aci Sanorania
3. Aci-sanorania
4. Acic
5. Aciclobeta
6. Aciclostad
7. Aciclovir
8. Aciclovir Alonga
9. Aciclovir Sanorania
10. Aciclovir Von Ct
11. Aciclovir-sanorania
12. Acifur
13. Acipen Solutab
14. Acivir
15. Activir
16. Acyclo V
17. Acyclo-v
18. Acycloguanosine
19. Acyclovir
20. Alonga, Aciclovir
21. Antiherpes Creme
22. Avirax
23. Cicloferon
24. Clonorax
25. Cusiviral
26. Genvir
27. Herpetad
28. Herpofug
29. Herpotern
30. Herpoviric
31. Isavir
32. Laciken
33. Mapox
34. Maynar
35. Milavir
36. Opthavir
37. Sodium, Acyclovir
38. Solutab, Acipen
39. Supraviran
40. Viclovir
41. Vipral
42. Virax Puren
43. Virax-puren
44. Viraxpuren
45. Virherpes
46. Virmen
47. Virolex
48. Virupos
49. Virzin
50. Wellcome 248u
51. Wellcome-248u
52. Wellcome248u
53. Zoliparin
54. Zovirax
55. Zyclir
1. Aciclovir Sodium
2. 69657-51-8
3. Sodium Acyclovir
4. Sodium 2-((2-amino-6-oxo-1h-purin-9(6h)-yl)methoxy)ethanolate
5. Acyclovir Sodium Salt
6. Bw 248u Sodium
7. Mfcd01694138
8. Bw-248u Sodium
9. Bw-248u-sodium
10. Sodium 2-amino-9-((2-hydroxyethoxy)methyl)-9h-purin-6-olate
11. Sodium 2-amino-9-[(2-hydroxyethoxy)methyl]purin-6-olate
12. 9-((2-hydroxyethoxy)methyl)guanine Monosodium Salt
13. Aciclovir Natrium
14. Bw 248u
15. Zovirax Sterile Powder
16. 927l42j563
17. Acycloguanosine Sodium (obs.)
18. Unii-927l42j563
19. 6h-purin-6-one, 2-amino-1,9-dihydro-9-((2-hydroxyethoxy)methyl)-, Monosodium Salt
20. Schembl40722
21. Chembl1200380
22. Bcp13172
23. Akos015896105
24. 2-amino-1,9-dihydro-9-((2-hydroxyethoxy)methyl)-6h-purin-6-one Monosodium Salt
25. As-12705
26. Sy027836
27. O12074
28. Q27271485
29. Sodium2-amino-9-((2-hydroxyethoxy)methyl)-9h-purin-6-olate
30. 6h-purin-6-one, 1,9-dihydro-2-amino-9-((2-hydroxyethoxy)methyl)-, Monosodium Salt
Molecular Weight | 247.19 g/mol |
---|---|
Molecular Formula | C8H10N5NaO3 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 4 |
Exact Mass | 247.06813348 g/mol |
Monoisotopic Mass | 247.06813348 g/mol |
Topological Polar Surface Area | 122 Ų |
Heavy Atom Count | 17 |
Formal Charge | 0 |
Complexity | 237 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Acyclovir sodium |
Drug Label | Acyclovir is a synthetic nucleoside analog active against herpes viruses. Acyclovir for Injection USP is a sterile lyophilized powder for intravenous administration only. Each 500 mg vial contains 500 mg of acyclovir and 49 mg of sodium, and each 100... |
Active Ingredient | Acyclovir sodium |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 50mg base/ml; eq 500mg base/vial; eq 1gm base/vial |
Market Status | Prescription |
Company | Bedford; Fresenius Kabi Usa; Aurobindo Pharma |
2 of 2 | |
---|---|
Drug Name | Acyclovir sodium |
Drug Label | Acyclovir is a synthetic nucleoside analog active against herpes viruses. Acyclovir for Injection USP is a sterile lyophilized powder for intravenous administration only. Each 500 mg vial contains 500 mg of acyclovir and 49 mg of sodium, and each 100... |
Active Ingredient | Acyclovir sodium |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 50mg base/ml; eq 500mg base/vial; eq 1gm base/vial |
Market Status | Prescription |
Company | Bedford; Fresenius Kabi Usa; Aurobindo Pharma |
Antiviral Agents
Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)
GDUFA
DMF Review : Complete
Rev. Date : 2015-02-20
Pay. Date : 2013-09-26
DMF Number : 10945
Submission : 1994-06-09
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 11829
Submission : 1996-01-24
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2020-10-06
Pay. Date : 2020-08-26
DMF Number : 35112
Submission : 2020-08-31
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 24289
Submission : 2010-10-15
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 29995
Submission : 2016-11-28
Status : Active
Type : II
IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.
About the Company : Established in 1990, Inabata France, a part of the Inabata Group, used to export chemical and pharmaceutical products to Japan. In 2006, it acquired Pharmasynthèse. Today, Inabata...
About the Company : Arihantanam Life Care Pvt. Ltd. is engaged in Manufacturing of Various Active Pharmaceuticals Ingredients Since 2006. We are a WHO-GMP approved facility and have installed moder...
About the Company : Fareva’s API division has special technologies for high potent APIs (HPAPIs) down to the OEB-6 level, aseptic crystallization (sterile APIs), Spray Drying etc, with volumes rangi...
About the Company : Rajasthan Antibiotics Limited (RAL-Life) is a fast track integrated pharmaceutical company which commenced its commercial production in 1991 and has grown in size and stature to b...
About the Company : Shouyuan chemical (one of the leading chemicals supplier in China) specializes in manufacturing, supplying, and custom synsthesis latest chemicals. Our products cover all kinds of ...
About the Company : Established in 2002, Tecoland represents selected cGMP manufacturers with proven capabilities in organic synthesis, fermentation production as well as process and method developmen...
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
A Acyclovir Sodium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Acyclovir Sodium, including repackagers and relabelers. The FDA regulates Acyclovir Sodium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Acyclovir Sodium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Acyclovir Sodium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Acyclovir Sodium supplier is an individual or a company that provides Acyclovir Sodium active pharmaceutical ingredient (API) or Acyclovir Sodium finished formulations upon request. The Acyclovir Sodium suppliers may include Acyclovir Sodium API manufacturers, exporters, distributors and traders.
click here to find a list of Acyclovir Sodium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Acyclovir Sodium DMF (Drug Master File) is a document detailing the whole manufacturing process of Acyclovir Sodium active pharmaceutical ingredient (API) in detail. Different forms of Acyclovir Sodium DMFs exist exist since differing nations have different regulations, such as Acyclovir Sodium USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Acyclovir Sodium DMF submitted to regulatory agencies in the US is known as a USDMF. Acyclovir Sodium USDMF includes data on Acyclovir Sodium's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Acyclovir Sodium USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Acyclovir Sodium suppliers with USDMF on PharmaCompass.
A Acyclovir Sodium written confirmation (Acyclovir Sodium WC) is an official document issued by a regulatory agency to a Acyclovir Sodium manufacturer, verifying that the manufacturing facility of a Acyclovir Sodium active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Acyclovir Sodium APIs or Acyclovir Sodium finished pharmaceutical products to another nation, regulatory agencies frequently require a Acyclovir Sodium WC (written confirmation) as part of the regulatory process.
click here to find a list of Acyclovir Sodium suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Acyclovir Sodium as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Acyclovir Sodium API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Acyclovir Sodium as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Acyclovir Sodium and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Acyclovir Sodium NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Acyclovir Sodium suppliers with NDC on PharmaCompass.
Acyclovir Sodium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Acyclovir Sodium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Acyclovir Sodium GMP manufacturer or Acyclovir Sodium GMP API supplier for your needs.
A Acyclovir Sodium CoA (Certificate of Analysis) is a formal document that attests to Acyclovir Sodium's compliance with Acyclovir Sodium specifications and serves as a tool for batch-level quality control.
Acyclovir Sodium CoA mostly includes findings from lab analyses of a specific batch. For each Acyclovir Sodium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Acyclovir Sodium may be tested according to a variety of international standards, such as European Pharmacopoeia (Acyclovir Sodium EP), Acyclovir Sodium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Acyclovir Sodium USP).
LOOKING FOR A SUPPLIER?